TS Financial Group (TSFG)’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3
Closed -$1K 895
2023
Q3
$1K Hold
3
﹤0.01% 894
2023
Q2
$1K Hold
3
﹤0.01% 887
2023
Q1
$1K Hold
3
﹤0.01% 866
2022
Q4
$1K Hold
3
﹤0.01% 885
2022
Q3
$1K Hold
3
﹤0.01% 858
2022
Q2
$1K Hold
3
﹤0.01% 874
2022
Q1
$2K Buy
+3
New +$1.81K ﹤0.01% 768

Other funds holding BIO

TS Financial Group (TSFG)'s BIO Position: Q4 2023 in Review

TS Financial Group (TSFG) sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2023, closing a stake of 3 shares — an estimated $1K sold.

TS Financial Group (TSFG) first reported a position in BIO in Q1 2022 and held it in 7 quarters. The position peaked at $2K in Q1 2022. 484 funds tracked by Wall St. Rank hold BIO as of Q4 2023.

  • TS Financial Group (TSFG) reported no remaining Bio-Rad Laboratories Class A position as of Q4 2023 after selling out during the quarter.
  • TS Financial Group (TSFG) sold 3 Bio-Rad Laboratories Class A shares in Q4 2023, an estimated $1K.
  • TS Financial Group (TSFG) first reported a position in Bio-Rad Laboratories Class A in Q1 2022 and held it in 7 quarters.
  • TS Financial Group (TSFG)'s Bio-Rad Laboratories Class A position peaked at $2K in Q1 2022.
  • 484 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2023.

Based on TS Financial Group (TSFG)'s 13F filing for Q4 2023, filed 24 Jan 2024.